Retransfusion or Not of Cardiotomy Blood

Örebro University, Sweden

Status: Unknown

Conditions: Blood Loss, Surgical

Treatments: Procedure: No retransfusion of cardiotomy blood

Study type: Interventional

Funder types: Other

Identifiers

NCT04574128

ECC 2020

Details and patient eligibility

About

This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Elective CABG.

Exclusion criteria

• Anaemia, infection, massive bleeding, CABG off pump.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Sequential Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Retransfusion of cardiotomy blood or not

Experimental group

Description:

Intervention group does not get cardiotomy blood retransfusion via heart-and lung machine while control does.

Treatment:

Procedure: No retransfusion of cardiotomy blood

No retransfusion of cardiotomy blood

No Intervention group